The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer. The study aims are: * To assess the effectiveness of the CCC model in improving patient outcomes. * To assess the effectiveness of the CCC model in increasing rates of SIC and advance care planning (ACP) record documentation. * To assess the acceptability of the CCC model to patients and clinicians. * To evaluate the feasibility of implementing a CCC model in oncology care. Researchers will compare results from the CCC intervention arm and usual care arm, to see if the CCC model can help improve patient outcomes and facilitate SIC between patients and clinicians. Patient participants will: * Follow the assignment of their clinician, who will be assigned randomly to either the usual care group or the intervention group. * Be assigned a CCC and receive 6 CCC sessions over the course of 3 months (if assigned to CCC intervention arm). * Complete 3 study assessment visits at baseline, Week 6, and 3 months * Be invited to a one-time interview to share their study experience (optional, if selected and if in CCC intervention arm).
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Communication Quality
Timeframe: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
Quality of Life per FACT-G7
Timeframe: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
Health Utility
Timeframe: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
Spiritual Well-Being
Timeframe: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
Healthcare Utilization - Rate of Unplanned Acute Hospital Utilization
Timeframe: From Study Enrolment to 3 months Post Enrolment.
Healthcare utilization - Length of hospital stay
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Hospital Bill
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Chemotherapy usage (type)
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Chemotherapy usage (line)
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Intensive care unit visit
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Length of intensive care unit visit
Timeframe: From Study Enrolment until Date of Death, up to 3 years.
Healthcare utilization - Location of death
Timeframe: From Study Enrolment until Date of Death, up to 3 years.